Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership725,822 shares
Latest Disclosed Value $ 29,257,885
Goldman Sachs Group Inc ownership in HTD / Corcept Therapeutics Incorporated

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 725,822 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $25,033,601 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 430,976 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 68.41% during the quarter. The current value of the position is $45,900,983 USD.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (HTD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:HTD / Corcept Therapeutics Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 725,822 294,846 68.41 29,258 95.09 0.0008
2026-02-10 2025-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 430,976 41,890 10.77 14,998 -53.62 0.0018
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 389,086 -171,583 -30.60 32,337 -21.42 0.0040
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 560,669 55,322 10.95 41,153 -28.70 0.0056
2025-06-27 2025-03-31 13F/A-2 CORCEPT THERAPEUTICS CMN 218352102 505,347 -120,899 -19.31 57,721 82.91 0.0093
2025-05-16 2025-03-31 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 505,347 -120,899 57,721 0.0024
2025-05-09 2025-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 505,347 -120,899 57,721 0.0017
2025-02-11 2024-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 626,246 153,225 32.39 31,557 44.15 0.0050
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 473,021 -5,553 -1.16 21,891 40.80 0.0035
2024-08-13 2024-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 478,574 43,852 10.09 15,549 41.99 0.0026
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 434,722 -98,038 -18.40 10,951 -36.72 0.0019
2024-05-14 2023-12-31 13F/A-2 CORCEPT THERAPEUTICS CMN 218352102 532,760 124,185 30.39 17,304 55.46 0.0032
2024-03-01 2023-12-31 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 532,760 17,304
2024-02-13 2023-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 532,760 124,185 17,304 0.0031
2024-05-15 2023-09-30 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 408,575 45,308 12.47 11,132 37.73 0.0024
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 408,575 45,308 11,132 0.0022
2024-05-14 2023-06-30 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 363,267 -40,164 -9.96 8,083 -7.51 0.0017
2023-08-15 2023-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 363,267 -40,164 8,083 0.0016
2024-05-14 2023-03-31 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 403,431 -70,770 -14.92 8,738 -9.27 0.0020
2023-05-11 2023-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 403,431 -70,770 8,738 0.0019
2024-05-14 2022-12-31 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 474,201 52,208 12.37 9,631 96,210.00 0.0024
2023-02-13 2022-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 474,201 52,208 9,631 0.0022
2024-05-14 2022-09-30 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 421,993 113,353 36.73 11 42.86 0.0027
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 421,993 113,353 10,820 0.0025
2024-05-14 2022-06-30 13F/A-2 CORCEPT THERAPEUTICS CMN 218352102 308,640 -39,946 -11.46 7 -99.91 0.0018
2022-08-18 2022-06-30 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 308,640 -39,946 7,339 0.0017
2022-08-15 2022-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 308,640 -39,946 7,339 0.0017
2022-05-16 2022-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 348,586 -2,760 -0.79 7,850 12.85 0.0016
2022-02-17 2021-12-31 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 351,346 -207,637 -37.15 6,956 -36.77 0.0014
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 351,346 -207,637 6,956 0.0004
2022-01-20 2021-09-30 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 558,983 165,748 42.15 11,001 27.16 0.0023
2021-11-10 2021-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 558,983 165,748 11,001 0.0023
2021-08-13 2021-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 393,235 -90,781 -18.76 8,651 -24.87 0.0019
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 484,016 -48,457 -9.10 11,515 -17.33 0.0029
2021-02-12 2020-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 532,473 55,759 11.70 13,929 67.86 0.0036
2020-11-13 2020-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 476,714 -483,997 -50.38 8,298 -48.65 0.0024
2020-08-12 2020-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 960,711 98,581 11.43 16,160 57.64 0.0049
2020-05-15 2020-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 862,130 398,019 85.76 10,251 82.53 0.0036
2020-02-14 2019-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 464,111 181,786 64.39 5,616 40.72 0.0014
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 282,325 68,355 31.95 3,991 67.27 0.0012
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 213,970 -335,867 -61.08 2,386 -63.04 0.0007
2019-05-15 2019-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 549,837 -29,794 -5.14 6,455 -16.65 0.0020
2019-02-14 2018-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 579,631 5,231 0.91 7,744 -3.84 0.0025
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 574,400 -264,977 -31.57 8,053 -38.97 0.0021
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 839,377 272,775 48.14 13,195 41.56 0.0036
2018-05-15 2018-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 566,602 -110,630 -16.34 9,321 -23.79 0.0024
2018-02-14 2017-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 677,232 45,669 7.23 12,231 0.34 0.0029
2017-11-14 2017-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 631,563 358,748 131.50 12,189 278.66 0.0030
2017-08-14 2017-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 272,815 57,523 26.72 3,219 36.46 0.0008
2017-05-18 2017-03-31 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 215,292 83,026 62.77 2,359 145.73 0.0006
2017-05-15 2017-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 215,292 2,359
2017-02-14 2016-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 132,266 7,473 5.99 960 18.37 0.0003
2016-11-14 2016-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 124,793 64,074 105.53 811 144.28 0.0002
2016-08-15 2016-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 60,719 9,765 19.16 332 39.50 0.0001
2016-05-13 2016-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 50,954 1,777 3.61 238 -2.46 0.0001
2016-02-16 2015-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 49,177 21,023 74.67 244 130.19 0.0001
2015-11-13 2015-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 28,154 -6,915 -19.72 106 -49.76 0.0000
2015-08-14 2015-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 35,069 35,069 24.56 211 99.06 0.0001
2014-11-14 2014-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 0 -163,159 -100.00 0 -100.00
2014-08-14 2014-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 163,159 135,442 488.66 457 277.69 0.0001
2014-05-15 2014-03-31 13F CORCEPT THERAPEUTICS CMN 218352102 27,717 5,942 27.29 121 72.86 0.0000
2014-02-14 2013-12-31 13F CORCEPT THERAPEUTICS CMN 218352102 21,775 6,425 41.86 70 191.67 0.0000
2013-11-14 2013-09-30 13F CORCEPT THERAPEUTICS CMN 218352102 15,350 15,350 -29.51 24 -65.71 0.0000
2013-08-14 2013-06-30 13F CORCEPT THERAPEUTICS CMN 218352102 0 -49,124 -100.00 0 -100.00
2013-06-14 2012-12-31 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 49,124 27,794 130.30 70 16.67 0.0000
2013-06-14 2012-09-30 13F/A-2 CORCEPT THERAPEUTICS CMN 218352102 21,330 -11,627 -35.28 60 -59.46 0.0000
2013-06-14 2012-06-30 13F/A-2 CORCEPT THERAPEUTICS CMN 218352102 32,957 -12,501 -27.50 148 -17.32 0.0001
2013-06-14 2012-03-31 13F/A-1 CORCEPT THERAPEUTICS CMN 218352102 45,458 45,458 179 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-13 2024-06-30 13F CORCEPT THERAPEUTICS CMN Call 30,000 975 n/a n/a n/a
2021-05-14 2021-03-31 13F CORCEPT THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-12 2020-12-31 13F CORCEPT THERAPEUTICS CMN Call 120,400 3,150 n/a n/a n/a
2018-02-14 2017-12-31 13F CORCEPT THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F CORCEPT THERAPEUTICS CMN Call 60,000 -12.92 1,158 327.31 n/a n/a n/a
2013-06-14 2012-06-30 13F/A CORCEPT THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-06-14 2012-03-31 13F/A CORCEPT THERAPEUTICS CMN Call 68,900 271 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-05-16 2022-03-31 13F CORCEPT THERAPEUTICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-17 2021-12-31 13F/A CORCEPT THERAPEUTICS CMN Put 16,700 0.00 331 0.61 n/a n/a n/a
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS CMN Put 16,700 331 n/a n/a n/a
2022-01-20 2021-09-30 13F/A CORCEPT THERAPEUTICS CMN Put 16,700 0.00 329 -10.35 n/a n/a n/a
2021-11-10 2021-09-30 13F CORCEPT THERAPEUTICS CMN Put 16,700 329 n/a n/a n/a
2021-08-13 2021-06-30 13F CORCEPT THERAPEUTICS CMN Put 16,700 367 n/a n/a n/a
2018-02-14 2017-12-31 13F CORCEPT THERAPEUTICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F CORCEPT THERAPEUTICS CMN Put 60,000 1,158 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.